This $4.79 Stock Has HUGE Potential

Описание: 💡 "How Wall St Picks Better Stocks." Join the Live Training https://felixfriends.org/training
Saturday 🗽9am NYC 💂2pm London 🌍3pm Europe

👤 Meet Felix Prehn:
I'm your host, Felix Prehn. My journey took me from being a novice investor to an investment banker, a corporate lawyer, and an entrepreneur. Investing was my key to early retirement at 40. My goal? To empower YOU to navigate the financial market with ease and transparency, free from the conventional financial system's noise. Let's embark on this journey to financial freedom together!

⚖️This is from my lovely lawyers:
The content in this video is for informational and educational purposes only. It does not constitute and should not be construed as financial or investment advice or an offer to purchase or sell securities. The content is not personalized or tailored to a specific person or group of persons, nor to their personal investment or financial needs. You should consult a financial adviser or other investment professional authorized to provide investment advice. Investing comes with risks, including the risk of loss. Presentations of trades made by Felix Prehn or Goat Academy Ltd or its personnel are not a guarantee that any investment decision made by a student will be successful. Past performance is not a guarantee of future performance.

Some of the accounts we highlight from time to time are our top performing accounts and the results shown are not typical. Trades shown may be from simulated trading or live trading accounts.
*CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN

Timestamps:
00:00 Intro
03:00 Why the Industry is Booming
03:53 Flow Cytometry Market Size
04:33 Five Drivers for Market Growth
06:40 Why US Investors Should Care
07:50 Company Positioning
09:10 Deep Dive into Cytek Biosciences (CTKB)
09:45 Proprietary Technology: Full Spectrum Profiling
10:50 How Cytek Makes Money (Revenue Streams)
11:43 The Importance of Recurring Revenue
11:53 Path to Profitability
12:33 The Stock Chart and Technical Analysis
13:37 Why Biotech Stocks Are Down (Interest Rates)
14:07 Competition (David vs. Goliath)
14:42 Investment Thesis Recap (The Bull Case)
15:17 Valuation and Financial Health
15:59 Razor and Blades Business Model
16:17 Additional Catalysts and Margins
17:10 Management and Stock Buybacks
17:59 Outro

#felixprehn #stockmarket